Results 91 to 100 of about 93,430 (253)

The Evolving Landscape of CHD Genetics: A Contemporary Guide to Genetic Testing and Management

open access: yesJournal of Paediatrics and Child Health, EarlyView.
ABSTRACT Congenital heart disease (CHD) is the most common birth defect, affecting an estimated 9.4/1000 infants globally. The genetics of CHD is complex, with most cases thought to have multifactorial aetiology, implicating both genetic and environmental factors.
Bridget R. O'Malley   +3 more
wiley   +1 more source

Seroprevalence of cytomegalovirus and rubella among pregnant women in western Sudan

open access: yesVirology Journal, 2011
Background Maternal cytomegalovirus (CMV) and rubella infections have adverse neonatal outcomes. Basic epidemiological data concerning CMV and rubella is necessary for health planners and care providers.
Nasser Nasser M   +3 more
doaj   +1 more source

Therapy With Doxycycline and Hydroxychloroquine Enables Surgical Excision of Ulcerated Cutaneous Granulomas in a Patient With Ataxia Telangiectasia

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT The rubella virus vaccine strain can cause granulomas in patients with inborn errors of immunity that may evolve into chronic, recalcitrant ulcers. This report details treatment of ulcerated rubella granulomas in a patient with ataxia telangiectasia with doxycycline and hydroxychloroquine resulting in partial ulcer healing within 4 weeks ...
Luis Murguía‐Favela   +6 more
wiley   +1 more source

Congenital rubella syndrome in Iran

open access: yesBMC Infectious Diseases, 2005
Background Congenital rubella syndrome (CRS) can be prevented with appropriate vaccination programs. The prevalence rates of rubella and CRS in Iran are unknown; therefore, the risk of exposure in pregnant women is not clear. The prevalence of CRS in the
Eftekhar Hasan   +2 more
doaj   +1 more source

Mumps and rubella surveillance in Victoria, 1993 to 2000 [PDF]

open access: yes, 2003
Despite improving childhood coverage of the measles-mumps-rubella vaccine (MMR) in Victoria during the 1990s, mumps and rubella notifications in age groups eligible for vaccination persisted.
Andrews, Ross M   +3 more
core   +1 more source

Trust Norms, Distrust, and Worst‐Case Defiance in the COVID‐19 Pandemic

open access: yesRegulation &Governance, EarlyView.
ABSTRACT When pandemics threaten, governments are expected to protect citizens. Trustworthiness and trust are central to meeting public expectations. Motivational posturing theory differentiates resistant and dismissive defiance during the COVID‐19 pandemic.
Valerie Braithwaite
wiley   +1 more source

Integrated Serologic Surveillance of Population Immunity and Disease Transmission. [PDF]

open access: yes, 2018
Antibodies are unique among biomarkers in their ability to identify persons with protective immunity to vaccine-preventable diseases and to measure past exposure to diverse pathogens. Most infectious disease surveillance maintains a single-disease focus,
Arnold, Benjamin F   +3 more
core   +1 more source

Impact of CD19 CAR T‐Cell Therapy on Pathogen‐Specific Antibody Titers in Lymphoma Patients

open access: yesTransplant Infectious Disease, EarlyView.
Patients with lymphoma undergoing CD19 CAR T‐cell therapy experience prolonged hypogammaglobulinemia and B‐cell aplasia. We investigate its impact on immunity against measles virus (MeV), mumps virus (MuV), rubella virus (RuV), varicella‐zoster virus (VZV), pneumococcal capsular polysaccharide, Haemophilus influenzae type B (Hib), and tetanus toxoid ...
Hayley Foy‐Stones   +15 more
wiley   +1 more source

Seroepidemiology of rubella in students of Arak University of Medical Sciences,Three years after national vaccination program

open access: yesMedical Laboratory Journal, 2009
Background and objectives: Since Rubella is an infectious disease with a few clinical symptoms, it is hardly diagnosed. Especially in the first trimester of pregnancy, congenital rubella is one of the major causes of neonatal mortality and permanent ...
A Ghazavi, M Khaki, N Mosakhani
doaj  

Preliminary Study on Type I Interferon as a Mucosal Adjuvant for Human Respiratory Syncytial Virus F Protein

open access: yesVaccines
Background: Human respiratory syncytial virus (HRSV) imposes a significant disease burden on infants and the elderly. Intranasal immunization using attenuated live vaccines and certain vector vaccines against HRSV has completed phase II clinical trials ...
Hongqiao Hu   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy